Date | Time | Source | Announcement |
---|---|---|---|
09 Sep 1999 | 08:51 AM | Preliminary Injunctions | |
31 Aug 1999 | 04:54 PM | Interim Dividend Notification | |
26 Aug 1999 | 04:00 PM | Directors' Dealings | |
23 Aug 1999 | 08:00 AM | Prilosec US Patent Cases | |
19 Aug 1999 | 09:00 AM | Injunction Upheld | |
03 Aug 1999 | 07:34 AM | First Interim Dividend | |
03 Aug 1999 | 07:33 AM | Interim Results - Part 3 | |
03 Aug 1999 | 07:32 AM | Interim Results - Part 2 | |
03 Aug 1999 | 07:31 AM | Interim Results - Part 1 |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.